Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Biological Fingerprints in CSF Differentiate Between Varying Dementias

By LabMedica International staff writers
Posted on 20 Oct 2011
The two most common forms of dementia are Alzheimer's disease and vascular dementia. More...
It is important to be able to make the correct diagnosis because the diseases are treated differently.

Vascular dementia is caused by reduced circulation in the small blood vessels of the brain, which can be picked up in brain scans as small infarcts--strokes--or widespread changes in the white matter. The problem is that this small vessel disease presents very similarly to Alzheimer's disease, making it difficult in practice to distinguish between the two.

Maria Bjerke from the Sahlgrenska Academy (Gothenburg, Sweden) at the University of Gothenburg showed that the different forms of dementia are detectable as biochemical changes in the cerebrospinal fluid (CSF) long before any clinical symptoms emerge. The results are significant for how the most common age-related cognitive disorders are diagnosed.

As the CSF is in direct contact with the brain, its molecular composition can be expected to reflect the brain's metabolism. Maria Bjerke explained, "Examining the molecular fingerprints in the CSF enables us to determine whether or not there is an ongoing pathological process. Mapping the biochemical differences between the various forms of dementia will help us to understand what caused the disease, which in turn will determine how the disease should be treated."

In July 2011 Prof. Göran Larson, from the department of psychiatry and neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, (Mölndal, Sweden) described the characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid β-peptides in human CSF from AD patients and controls.

Prof. Larson commented, ''Dementia is a major and growing problem not just for healthcare but for society as a whole since more people are getting older and older, and the single largest risk factor for Alzheimer's is just that--old age," says Larson. "There isn't currently any effective pharmaceutical treatment for Alzheimer's, but if this discovery can contribute to an early diagnosis then medicines that slow the progression of the disease can be tried before the dementia gets too severe.

"If we can link the formation of these molecules to the disease mechanisms behind Alzheimer's, then there's hope that we can also develop new drugs that can affect the course of this serious disease."

With more than 100,000 people affected in Sweden, Alzheimer's is one of the most common diseases of the society. Caused by changes in the brain tissue, the disease predominantly affects the memory and often leads to an earlier death. Alzheimer's disease results in not only considerable suffering for patients and their families, but also in huge costs to society.

Related Links:

Sahlgrenska Academy at the University of Gothenburg
University of Gothenburg





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.